Trastuzumab (Herceptin) Biosimilars — Save Thousands
FDA-approved biosimilars for Trastuzumab (Herceptin) offer the same efficacy and safety at up to 50% lower cost — saving up to $4,500/year. Script Unlock connects you with pharmacies offering biosimilar pricing.
Reference product
$9,000
Trastuzumab (Herceptin)
Biosimilar price
from $4,500
save up to 50%
FDA-Approved Trastuzumab (Herceptin) Biosimilars
KanjintiHerzumaOgivriOntruzant
Are Biosimilars as Effective as Trastuzumab (Herceptin)?
- FDA requires biosimilars to have no clinically meaningful differences in safety or efficacy
- Same active ingredient, same mechanism of action
- Interchangeable biosimilars can be substituted without prescriber intervention
- Extensive clinical studies required before FDA approval